83-5598-44　CLS-CD-3575 Cells 1vial　400146

特徴

• 概要：CLS-CD-3575 cells, a remarkable biological tool derived from the sampling site of the kidney in Mus musculus (Mouse).
• These cells hold great potential for advancing our understanding of cancer, particularly in the context of mouse kidney carcinoma.
• The CLS-CD-3575 cells provide researchers with a valuable resource for studying the intricate mechanisms underlying cancer development and progression.
• Derived specifically from mouse kidney carcinoma, these cells offer a reliable model system to investigate the complex biological processes associated with this type of cancer.
• These cells are invaluable in cancer research, enabling scientists to explore various aspects of tumour biology, such as cell signalling, proliferation, migration, and invasion.
• By utilizing CLS-CD-3575 cells, researchers can gain valuable insights into the molecular pathways of mouse kidney carcinoma, shedding light on potential therapeutic targets and novel treatment strategies.
• Moreover, these cells are a robust platform for drug discovery and preclinical studies.
• Researchers can employ the CLS-CD-3575 cells to evaluate the efficacy of anti-cancer agents and assess their impact on tumour growth and viability.
• This empowers scientists to identify promising compounds with potential for future therapeutic interventions against mouse kidney carcinoma.
• With their origin from mouse kidney carcinoma, the CLS-CD-3575 cells closely resemble the characteristics and behaviour of cancer cells found in this specific type of cancer.
• This fidelity to the in vivo environment enables researchers to obtain reliable and representative results, enhancing the translational potential of their findings.
• The availability of CLS-CD-3575 cells opens up new avenues for studying mouse kidney carcinoma and contributes to our overall understanding of cancer biology.
• By harnessing the power of these cells, researchers can uncover novel insights into the underlying mechanisms driving tumour formation and progression.
• Ultimately, this knowledge can pave the way for developing targeted therapies and personalized medicine approaches, bringing us closer to effectively combating mouse kidney carcinoma and improving patient outcomes.
• The CLS-CD-3575 cells provide a robust and reliable experimental system for investigating mouse kidney carcinoma.
• Their close resemblance to the in vivo tumour environment allows researchers to delve into the intricacies of this cancer type, uncovering vital information for therapeutic advancements.
• By utilizing these cells, scientists can accelerate progress in cancer research, bringing us one step closer to conquering mouse kidney carcinoma and other related malignancies.